ETF Factsheet · Health

iShares Global Healthcare ETF (IXJ)

IXJ ETF sheet: fees, AUM, composition, allocation and performance, based on the positions published by the issuer.

Theme HealthIssuer ISharesClass EquityDomicile United StatesPEA no (fund domiciled outside Europe)
Symbol IXJ·ISIN US4642873255·Created on 2001-11-13·Positions at 2026-11-08·Sheet of the 14/11/2026
Annual fees
0,38 %
deducted from the share value
Outstanding
4,64 $bn
in US dollars
Number of lines
124
published positions
Weight of the top 10
47,3 %
concentration
Performance 1 year
+19,3 %
price in USD
3 year performance
+41,6 %
i.e. +12,3 % per year
5 year performance
+31,3 %
i.e. +5,6 % per year
Volatilité 1 an
16,3 %
annualized standard deviation
Worst drop
-18,7 %
from a high, 5 years
Last share price
114,74 USD
+0,42 % during the session
Reading. Fees of 0,38 % per year represent 38 € deducted each year for every € 10 000 invested, directly in the share value. Health ETFs combine pharmaceuticals, medical equipment and biotechnologies: a defensive sector in the United States, more cyclical in its biotech part. The positions come from the issuer's publications; performance is calculated on the closing prices of the IXJ listing, dividends not reinvested, in the listing currency.

10 first linesweight in the fund

11,10 %
Johnson & JohnsonUS4781601046
6,82 %
AbbVie Inc.US00287Y1091
5,27 %
Merck & Co., Inc.US58933Y1055
4,07 %
ROCHE PS PAR AGROP.SW
3,77 %
Novartis AGCH0012005267
3,35 %
ASTRAZENECA PLCAZN.L
3,25 %
2,89 %
Amgen Inc.US0311621009
2,80 %

Sectorsaccording to the issuer

Pharma, Biotech & Life Sciences
70,96 %
Health Care Equipment & Services
28,67 %
Cash and/or Derivatives
0,36 %

Countryaccording to the issuer

United States
72,63 %
Switzerland
9,76 %
United Kingdom
5,04 %
Japan
3,64 %
France
2,05 %
Denmark
1,94 %
Germany
1,72 %
Other
1,09 %
Belgium
1,08 %
Australia
1,04 %

What you need to know

Classic index fund: first compare the fees and recovery with what you already hold.

Composition: the 50 largest positions

#LineWeightValue
1Eli Lilly and CompanyUS532457108311,10 %516,1 M$
2Johnson & JohnsonUS47816010466,82 %317,1 M$
3AbbVie Inc.US00287Y10915,27 %245,2 M$
4Merck & Co., Inc.US58933Y10554,07 %189,3 M$
5UnitedHealth Group IncorporatedUS91324P10213,99 %185,3 M$
6ROCHE PS PAR AGROP.SW3,77 %175,1 M$
7Novartis AGCH00120052673,35 %155,6 M$
8ASTRAZENECA PLCAZN.L3,25 %151,2 M$
9Thermo Fisher Scientific Inc.US88355610232,89 %134,6 M$
10Amgen Inc.US03116210092,80 %130,4 M$
11Gilead Sciences, Inc.US37555810362,33 %108,4 M$
12Abbott LaboratoriesUS00282410002,14 %99,6 M$
13Pfizer Inc.US71708110351,89 %87,7 M$
14Intuitive Surgical, Inc.US46120E60231,80 %83,8 M$
15Danaher CorporationUS23585110281,62 %75,5 M$
16Vertex Pharmaceuticals IncorporatedUS92532F10031,56 %72,6 M$
17Novo Nordisk A/SDK00624983331,44 %67,0 M$
18Bristol-Myers Squibb CompanyUS11012210831,43 %66,5 M$
19Medtronic plcIE00BTN1Y1151,40 %65,3 M$
20McKesson CorporationUS58155Q10311,39 %64,8 M$
21Stryker CorporationUS86366710131,28 %59,6 M$
22CVS Health CorporationUS12665010061,21 %56,2 M$
23GLAXOSMITHKLINEGSK.L1,15 %53,5 M$
24SanofiFR00001205781,14 %52,8 M$
25Moderna, Inc.US60770K10791,06 %49,5 M$
26Elevance Health Inc.US03675210381,04 %48,3 M$
27Regeneron Pharmaceuticals, Inc.US75886F10751,00 %46,4 M$
28Cigna CorporationUS12552310030,87 %40,6 M$
29HCA Healthcare, Inc.US40412C10180,82 %38,2 M$
30TAKEDA PHARMACEUTICAL4502.T0,75 %34,9 M$
31CSLCSL.AX0,75 %34,8 M$
32Cencora, Inc.US03073E10550,72 %33,3 M$
33Cardinal Health, Inc.US14149Y10820,71 %33,1 M$
34EssilorLuxottica S.A.FR00001216670,71 %33,1 M$
35Boston Scientific CorporationUS10113710770,70 %32,4 M$
36Bayer AGDE000BAY00170,69 %31,9 M$
37Edwards Lifesciences CorporationUS28176E10820,66 %30,8 M$
38Becton, Dickinson and CompanyUS07588710910,65 %30,2 M$
39ARGENXARGX.BR0,64 %29,8 M$
40Lonza Group AGCH00138410170,64 %29,7 M$
41IDEXX Laboratories, Inc.US45168D10460,60 %27,9 M$
42Humana Inc.US44485910280,59 %27,3 M$
43Agilent Technologies, Inc.US00846U10160,56 %25,8 M$
44HOYA7741.T0,53 %24,8 M$
45Veeva Systems Inc.US92247510840,51 %23,8 M$
46Waters CorporationUS94184810350,51 %23,5 M$
47Sandoz Group AGCH12435984270,51 %23,5 M$
48IQVIA Holdings Inc.US46266C10530,50 %23,4 M$
49Galderma Group NCH13353927210,49 %22,8 M$
50HALEON PLCHLN.L0,45 %20,9 M$

Comparable ETFs

The overlap measures the part of the portfolio common to both funds (sum of minimum weights on shared lines): beyond 70 %, holding both provides almost no diversification.

ETFFeesOutstandingPerf. 1 yearRecovery
Xtrackers MSCI World Health Care UCITS ETF 1CXDWH.DE · Xtrackers0,25 %4,61 $bn+24,6 %94,2 %compare
iShares S&P 500 Health Care Sector UCITS ETFQDVG.DE · IShares0,15 %3,58 $bn+30,5 %73,0 %compare
State Street Health Care Select Sector SPDR ETFXLV · SPDR0,08 %49,69 $bn+23,6 %73,0 %compare
Fidelity MSCI Health Care Index ETFFHLC · Fidelity0,08 %3,95 $bn+23,1 %73,0 %compare
Vanguard Health Care ETFVHT · Vanguard0,09 %19,10 $bn+22,6 %72,8 %compare
iShares U.S. Healthcare ETFIYH · IShares0,37 %4,73 $bn+22,9 %68,8 %compare
iShares Future Exponential Technologies ETFXT · IShares0,46 %3,81 $bn+11,5 %28,9 %compare
iShares MSCI Europe Health Care Sector UCITS ETFESIH.DE · IShares0,18 %1,06 $bnn.d.21,7 %compare

Its holdings in other ETFsdouble exposure

The main holdings of IXJ are found in many other funds: holding several ETFs often means holding the same companies multiple times.

  • Eli Lilly and Company : 11,10 % in this fund; held by 1 003 ETF, 204,86 Bn$ in total
  • Johnson & Johnson : 6,82 % in this fund; held by 942 ETF, 121,50 Bn$ in total
  • AbbVie Inc. : 5,27 % in this fund; held by 931 ETF, 89,91 Bn$ in total
  • Merck & Co., Inc. : 4,07 % in this fund; held by 959 ETF, 73,55 Bn$ in total
  • UnitedHealth Group Incorporated : 3,99 % in this fund; held by 853 ETF, 72,16 Bn$ in total
  • Novartis AG : 3,35 % in this fund; held by 526 ETF, 33,22 Bn$ in total
  • Thermo Fisher Scientific Inc. : 2,89 % in this fund; held by 663 ETF, 41,62 Bn$ in total
  • Amgen Inc. : 2,80 % in this fund; held by 902 ETF, 62,68 Bn$ in total

Information provided for educational purposes from the positions published by the issuers and closing prices. Past performance is not indicative of future performance; fees and assets under management are those declared by the source and may contain errors. Investing involves a risk of capital loss.

Frequently Asked Questions

To understand well

What are the fees of the IXJ ETF?
Reported ongoing fees are 0,38 % per year. Fees of 0,38 % per year represent 38 € collected each year for every 10 000 € invested, directly in the share value.
What are the largest positions of iShares Global Healthcare ETF?
The first ten lines weigh 47,3 % of the fund: Eli Lilly and Company (11,1 %), Johnson & Johnson (6,8 %), AbbVie Inc. (5,3 %), Merck & Co., Inc. (4,1 %), UnitedHealth Group Incorporated (4,0 %).
Is the IXJ ETF eligible for the PEA?
No: the fund is domiciled outside the European Economic Area (ISIN US4642873255), it cannot be held in a PEA. It remains accessible in a securities account.
What is the performance of IXJ over 5 years?
+31,3 % over 5 years, i.e., +5,6 % per year, in USD and dividends not reinvested (closing price at 2026-11-13).

← All ETF tools